EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients

Maëlle Le Goff iD, Eric Kendjo, Marc Thellier, Renaud Piarroux, Pierre-Yves Boelle, Stéphane Jauréguiberry iD, French National Reference Centre for Imported Malaria Study Group

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac641 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Maëlle Le Goff und 6 weiteren Autor:innen. Beteiligte Einrichtung: Université de Bretagne Occidentale, Service des maladies infectieuses et tropicales, Centre Hospitalier Régional Universitaire La Cavale Blanche, Bre…. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium ovale, Malaria, Malaria, Vivax. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Malaria National Reference Centre, French Public Health Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of chemoprophylaxis targeting Plasmodium falciparum on Plasmodium vivax and Plasmodium ovale, which may remain quiescent as hypnozoites in the liver, is debated.

Methods

We conducted a nested case-control analysis of the outcomes of P. vivax and P. ovale infections in imported malaria cases in France among civilian travelers from 1 January 2006, to 31 December 2017. Using adjusted logistic regression, we assessed the effect of chemoprophylaxis on the incubation period, time from symptoms to diagnosis, management, blood results, symptoms, and hospitalization duration. We analyzed the effect of blood-stage drugs (doxycycline, mefloquine, chloroquine, chloroquine-proguanil) or atovaquone-proguanil on the incubation period. We used a counterfactual approach to ascertain the causal effect of chemoprophylaxis on postinfection characteristics.

Results

Among 247 P. vivax– and 615 P. ovale–infected travelers, 30% and 47%, respectively, used chemoprophylaxis, and 7 (3%) and 8 (1%) were severe cases. Chemoprophylaxis users had a greater risk of presenting symptoms >2 months after returning for both species (P. vivax odds ratio [OR], 2.91 [95% confidence interval {CI}, 1.22–6.95], P = .02; P. ovale OR, 2.28 [95% CI, 1.47–3.53], P < .001). Using drugs only acting on the blood stage was associated with delayed symptom onset after 60 days, while using atovaquone-proguanil was not.

Conclusions

Civilian travelers infected with P. vivax or P. ovale reporting chemoprophylaxis use, especially of blood-stage agents, had a greater risk of delayed onset of illness. The impact of chemoprophylaxis on the outcomes of infection with relapse-causing species calls for new chemoprophylaxis acting against erythrocytic and liver stages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsPlasmodium ovaleMalariaMalaria, VivaxHumansAtovaquonePlasmodium vivaxCase-Control StudiesTravelChloroquineChemoprevention

Stichwörter der Autor:innen

Plasmodium ovalePlasmodium vivaxchemoprophylaxismalariatravelers

Substanzen

AtovaquoneAntimalarialsChloroquine

Autor:innen und Institutionen

  • Université de Bretagne Occidentale, Service des maladies infectieuses et tropicales, Centre Hospitalier Régional Universitaire La Cavale Blanche, Brest, France.
  • Sorbonne Université, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Inserm, Paris, France.
  • Centre National de Référence du Paludisme, Paris, France.
  • Sorbonne Université, Service de parasitologie, Hôpital Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, Paris, France.
  • Université de Paris Saclay, Service des maladies infectieuses et tropicales, Hôpital Bicêtre, Assistance Publique - Hôpitaux de Paris, Le Kremlin Bicêtre, France.
  • Société Française de Médecine des Voyages, Paris, France.

ORCID-Profile: Maëlle Le Goff, Stéphane Jauréguiberry

Förderung

  • Malaria National Reference Centre
  • French Public Health Agency

Zitieren

APA

Le Goff, M., Kendjo, E., Thellier, M., Piarroux, R., Boelle, P. Y., Jauréguiberry, S., & French National Reference Centre for Imported Malaria Study Group (2023). Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac641

Vancouver

Le Goff M, Kendjo E, Thellier M, Piarroux R, Boelle PY, Jauréguiberry S, et al. Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac641

BibTeX
@article{LeGoff2023,
  author = {Le Goff, Maëlle and Kendjo, Eric and Thellier, Marc and Piarroux, Renaud and Boelle, Pierre-Yves and Jauréguiberry, Stéphane and French National Reference Centre for Imported Malaria Study Group, French National Reference Centre for Imported Malaria Study Group},
  title = {Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac641}
}
Kostenlos starten →